Yuzhu Lotus Seed Eight Treasure Soup
| FOB Price: | US$2.82 / Bag |
|---|---|
| Min. Order: | 1,000 Bags |
| Min. Order | FOB Price |
|---|---|
| 1,000 Bags | US$2.82 |
| Port: | Shanghai, China |
|---|---|
| Payment Terms: | Paypal |
Similar Items
Loading...
You May Like
Loading...
Product Description
Company Info
Address:
No. 88, National Highway 312, Danfeng County, Shangluo, Shaanxi, China
Business Type:
Manufacturer/Factory
Business Range:
Agriculture & Food, Chemicals, Health & Medicine, Instruments & Meters, Packaging & Printing
Management System Certification:
GMP
Company Introduction:
Shaanxi Xinyudan Traditional Chinese Medicine Biotechnology Co., Ltd. Was established in December 2018. It is a key enterprise for investment attraction in cooperation between Jiangsu and Shaanxi and Yudan. The company mainly produces and operates traditional Chinese medicine decoction pieces, traditional Chinese medicine and formula granules, plant extracts, big data and cross-border e-commerce platforms for traditional Chinese medicine, and commercial logistics for traditional Chinese medicine. Starting from July 2020, the total investment is 680 million yuan, with a land acquisition of 140 acres and construction in two phases; The first phase has built a 35000 square meter Chinese herbal medicine technology industrial park: The most advanced Chinese herbal medicine testing and inspection center in Northwest China, the national reserve base for Chinese herbal medicine logistics in Shaanxi (Shangluo), the first intelligent decoction and preparation operation center in Northwest China, the largest toxic decoction piece workshop in Northwest China, and the ordinary decoction piece production workshop. The second phase of the 38000 square meter "Food and Drug Park Project" includes the emergency medical material reserve warehouse in Shangluo City, production workshops for traditional Chinese and Western medicine preparations, functional food production workshops, and medical device production workshops. The company′s research project on low-dose atropine eye drops and development of nano antibody conjugated drugs has entered Phase II of animal testing, and has attracted attention from multiple venture capital funds; Since the completion of the first phase project, the annual sales revenue has reached 120 million yuan.
){kind=link}